Header Logo

Connection

ANAIS MALPICA to Immunohistochemistry

Back to Details
This is a "connection" page, showing publications ANAIS MALPICA has written about Immunohistochemistry.
ANAIS MALPICA
Connection Strength
1.662
Immunohistochemistry
  1. Use of immunohistochemistry in the diagnosis of miscellaneous and metastatic tumors of the uterine corpus and cervix. Semin Diagn Pathol. 2014 May; 31(3):233-57.
    View in: PubMed
    Score: 0.212
  2. Dermatofibrosarcoma protuberans of the vulva: a clinicopathologic and immunohistochemical study of 13 cases. Am J Surg Pathol. 2010 Mar; 34(3):393-400.
    View in: PubMed
    Score: 0.159
  3. Malignant Peritoneal Mesothelioma Associated With Endometriosis: A Clinicopathologic Study of 15 Cases. Int J Gynecol Pathol. 2022 Jan 01; 41(1):59-67.
    View in: PubMed
    Score: 0.090
  4. Ultrastaging of Sentinel Lymph Nodes in Endometrial Carcinoma According to Use of 2 Different Methods. Int J Gynecol Pathol. 2018 May; 37(3):242-251.
    View in: PubMed
    Score: 0.070
  5. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers. Int J Gynecol Pathol. 2016 Sep; 35(5):410-8.
    View in: PubMed
    Score: 0.062
  6. Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases. Am J Surg Pathol. 2016 May; 40(5):577-86.
    View in: PubMed
    Score: 0.061
  7. Collision of Ductal Carcinoma In Situ of Anogenital Mammary-like Glands and Vulvar Sarcomatoid Squamous Cell Carcinoma. Int J Gynecol Pathol. 2015 Sep; 34(5):487-94.
    View in: PubMed
    Score: 0.058
  8. Endometrioid stromal sarcoma: a clinicopathologic study of 63 cases. Am J Surg Pathol. 2013 Nov; 37(11):1635-47.
    View in: PubMed
    Score: 0.051
  9. Low-grade smooth muscle tumors of the primary and the secondary mullerian system: a proposed concept of multicentricity. Int J Gynecol Pathol. 2012 Nov; 31(6):547-55.
    View in: PubMed
    Score: 0.048
  10. Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma. Am J Surg Pathol. 2012 Jul; 36(7):955-63.
    View in: PubMed
    Score: 0.047
  11. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol. 2012 Jan; 36(1):117-27.
    View in: PubMed
    Score: 0.045
  12. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary. Int J Gynecol Pathol. 2011 Nov; 30(6):613-9.
    View in: PubMed
    Score: 0.045
  13. Angiosarcoma arising in mature cystic teratoma of the ovary: a case report and review of the literature. Int J Gynecol Pathol. 2009 Sep; 28(5):453-7.
    View in: PubMed
    Score: 0.038
  14. Primary retroperitoneal mucinous tumors: a clinicopathologic study of 18 cases. Am J Surg Pathol. 2009 Apr; 33(4):526-33.
    View in: PubMed
    Score: 0.037
  15. Growing teratoma syndrome of the ovary: review of literature and first report of a carcinoid tumor arising in a growing teratoma of the ovary. Am J Surg Pathol. 2007 Dec; 31(12):1913-8.
    View in: PubMed
    Score: 0.034
  16. Undifferentiated carcinoma of the endometrium: a review. Pathology. 2007 Feb; 39(1):134-8.
    View in: PubMed
    Score: 0.032
  17. Ovarian involvement by metastatic colorectal adenocarcinoma: still a diagnostic challenge. Am J Surg Pathol. 2006 Feb; 30(2):177-84.
    View in: PubMed
    Score: 0.030
  18. Malignant melanoma involving the ovary: a clinicopathologic and immunohistochemical study of 23 cases. Am J Surg Pathol. 2004 Jun; 28(6):771-80.
    View in: PubMed
    Score: 0.027
  19. Uterine epithelioid leiomyosarcomas with clear cells: reactivity with HMB-45 and the concept of PEComa. Am J Surg Pathol. 2004 Feb; 28(2):244-9.
    View in: PubMed
    Score: 0.026
  20. Immunohistochemistry in gynecological pathology. Int J Gynecol Cancer. 2003 Sep-Oct; 13(5):567-79.
    View in: PubMed
    Score: 0.025
  21. Tissue macroarray: a simple and cost-effective method for high-throughput studies. Appl Immunohistochem Mol Morphol. 2003 Jun; 11(2):174-6.
    View in: PubMed
    Score: 0.025
  22. Metastatic melanoma to the vagina: clinicopathologic and immunohistochemical study of three cases and literature review. Int J Gynecol Pathol. 2003 Apr; 22(2):136-40.
    View in: PubMed
    Score: 0.025
  23. Urinary bladder leiomyoma during pregnancy: report of one case with immunohistochemical studies. J Obstet Gynaecol. 2002 Nov; 22(6):683-5.
    View in: PubMed
    Score: 0.024
  24. Primitive neuroectodermal tumor of the cervix: a clinicopathologic and immunohistochemical study of two cases. Ann Diagn Pathol. 2002 Oct; 6(5):281-7.
    View in: PubMed
    Score: 0.024
  25. Immunohistochemical Loss of DPC4 in Tumors With Mucinous Differentiation Arising in or Involving the Gynecologic Tract. Int J Gynecol Pathol. 2021 Nov 01; 40(6):523-532.
    View in: PubMed
    Score: 0.022
  26. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S114-S122.
    View in: PubMed
    Score: 0.018
  27. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S40-S63.
    View in: PubMed
    Score: 0.018
  28. Yolk Sac Tumor in Extragonadal Pelvic Sites: Still a Diagnostic Challenge. Am J Surg Pathol. 2017 01; 41(1):1-11.
    View in: PubMed
    Score: 0.016
  29. Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases. Am J Surg Pathol. 2016 06; 40(6):847-56.
    View in: PubMed
    Score: 0.015
  30. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases. Mod Pathol. 2015 Dec; 28(12):1613-20.
    View in: PubMed
    Score: 0.015
  31. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases. Hum Pathol. 1994 Apr; 25(4):390-5.
    View in: PubMed
    Score: 0.013
  32. Co-existence of a large ovarian hemangioma and microscopic dysgerminoma in a 10-year old child. Turk Patoloji Derg. 2014; 30(3):210-4.
    View in: PubMed
    Score: 0.013
  33. Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade? PLoS One. 2013; 8(10):e75899.
    View in: PubMed
    Score: 0.013
  34. Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T1?2N0M0 breast cancer. Pol J Pathol. 2013 Apr; 64(1):1-8.
    View in: PubMed
    Score: 0.012
  35. Malignant melanoma arising in an ovarian carcinosarcoma: case report and review of the literature. Int J Gynecol Pathol. 2011 Mar; 30(2):158-62.
    View in: PubMed
    Score: 0.011
  36. Molecular biomarkers in endometrial hyperplasias predict cancer progression. Am J Obstet Gynecol. 2011 Apr; 204(4):357.e1-12.
    View in: PubMed
    Score: 0.011
  37. Expression of the retinoblastoma-related gene Rb2/p130 in the pathogenesis of serous carcinoma of the ovary. Appl Immunohistochem Mol Morphol. 2010 Dec; 18(6):509-11.
    View in: PubMed
    Score: 0.010
  38. Local immune response in the microenvironment of CIN2-3 with and without spontaneous regression. Mod Pathol. 2010 Sep; 23(9):1231-40.
    View in: PubMed
    Score: 0.010
  39. Endometrial endometrioid adenocarcinoma of the uterine corpus involving the cervix: some cases probably represent independent primaries. Int J Gynecol Pathol. 2010 Mar; 29(2):146-56.
    View in: PubMed
    Score: 0.010
  40. PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas. Mod Pathol. 2009 Sep; 22(9):1243-50.
    View in: PubMed
    Score: 0.009
  41. Immunohistochemical studies of trophoblastic tumors. Am J Surg Pathol. 2009 Apr; 33(4):633-8.
    View in: PubMed
    Score: 0.009
  42. The significance of neuroendocrine expression in undifferentiated carcinoma of the endometrium. Int J Gynecol Pathol. 2009 Mar; 28(2):142-7.
    View in: PubMed
    Score: 0.009
  43. Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol. 2008 Sep; 32(9):1336-43.
    View in: PubMed
    Score: 0.009
  44. Thyroid transcription factor-1 expression in ovarian epithelial neoplasms. Mod Pathol. 2008 Apr; 21(4):485-90.
    View in: PubMed
    Score: 0.009
  45. Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis. Int J Gynecol Pathol. 2007 Oct; 26(4):404-9.
    View in: PubMed
    Score: 0.008
  46. Immunohistochemical overexpression of p16 and p53 in uterine serous carcinoma and ovarian high-grade serous carcinoma. Int J Gynecol Pathol. 2007 Jul; 26(3):328-33.
    View in: PubMed
    Score: 0.008
  47. Cyclin E expression is correlated with tumor progression and predicts a poor prognosis in patients with ovarian carcinoma. Cancer. 2006 May 01; 106(9):1925-32.
    View in: PubMed
    Score: 0.008
  48. Discordant genetic changes in ovarian and endometrial endometrioid carcinomas: a potential pitfall in molecular diagnosis. Int J Gynecol Cancer. 2006 Jan-Feb; 16(1):178-82.
    View in: PubMed
    Score: 0.007
  49. Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps. Am J Surg Pathol. 2005 Aug; 29(8):1074-8.
    View in: PubMed
    Score: 0.007
  50. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas. Am J Surg Pathol. 2004 Nov; 28(11):1499-505.
    View in: PubMed
    Score: 0.007
  51. Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol. 2004 Jul; 17(7):790-7.
    View in: PubMed
    Score: 0.007
  52. Skene's gland adenocarcinoma resembling prostatic adenocarcinoma. Int J Gynecol Pathol. 2004 Jan; 23(1):71-4.
    View in: PubMed
    Score: 0.006
  53. Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium. Cancer. 2003 Aug 15; 98(4):758-64.
    View in: PubMed
    Score: 0.006
  54. Uterine tumor resembling ovarian sex-cord tumor: report of a case mimicking cervical adenocarcinoma. Int J Gynecol Pathol. 2003 Jul; 22(3):297-302.
    View in: PubMed
    Score: 0.006
  55. Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin. Int J Gynecol Pathol. 2003 Apr; 22(2):162-7.
    View in: PubMed
    Score: 0.006
  56. beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma. Gynecol Oncol. 2003 Mar; 88(3):363-8.
    View in: PubMed
    Score: 0.006
  57. Vaginal melanoma: a clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 2002 Nov; 26(11):1450-7.
    View in: PubMed
    Score: 0.006
  58. Non-Hodgkin's lymphoma involving the vulva. Int J Gynecol Pathol. 2000 Jul; 19(3):236-42.
    View in: PubMed
    Score: 0.005
  59. Primary vulvar and vaginal extraosseous Ewing's sarcoma/peripheral neuroectodermal tumor: diagnostic confirmation with CD99 immunostaining and reverse transcriptase-polymerase chain reaction. Int J Gynecol Pathol. 2000 Apr; 19(2):103-9.
    View in: PubMed
    Score: 0.005
  60. Primary ovarian rhabdomyosarcoma associated with clear cell carcinoma of the ovary: a case report and review of the literature. Int J Gynecol Pathol. 2000 Apr; 19(2):169-73.
    View in: PubMed
    Score: 0.005
  61. Dermatofibrosarcoma protuberans of the vulva: clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature. Int J Gynecol Pathol. 1999 Oct; 18(4):366-73.
    View in: PubMed
    Score: 0.005
  62. Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial. Clin Cancer Res. 1998 Jun; 4(6):1383-91.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.